Zemplar and Panic attacks - a phase IV clinical study of FDA data

Summary:

Panic attacks is reported as a side effect among people who take Zemplar (paricalcitol), especially for people who are female, 30-39 old, also take Clonazepam, and have Abdominal pain.

The phase IV clinical study analyzes which people have Panic attacks when taking Zemplar. It is created by eHealthMe based on reports of 15,456 people who have side effects when taking Zemplar from the FDA, and is updated regularly.

What is Zemplar?

Zemplar has active ingredients of paricalcitol. It is often used in kidney disease. eHealthMe is studying from 15,494 Zemplar users. Check the latest studies of Zemplar.

What is Panic attacks?

Panic attacks is found to be associated with 2,290 drugs and 2,077 conditions by eHealthMe. Check the latest studies of Panic attacks.

On Jun, 25, 2026

15,456 people reported to have side effects when taking Zemplar.
Among them, 8 people (0.05%) have Panic attacks.

Among these 8 people:

What is the gender of people who have Panic attacks when taking Zemplar? *

female: 57.14 %
male: 42.86 %

What is the age of people who have Panic attacks when taking Zemplar? *

What are other drugs people take besides Zemplar? *

What are other side effects people have besides Panic attacks? *

Nausea (feeling of having an urge to vomit): 4 people, 50.00%
Stress And Anxiety: 3 people, 37.50%
Weakness: 2 people, 25.00%
Rectal Haemorrhage (bleeding from anus): 2 people, 25.00%
Fungal Infection: 2 people, 25.00%
Gait Disturbance: 2 people, 25.00%
Dyspnea (difficult or laboured breathing): 2 people, 25.00%
High Blood Pressure: 2 people, 25.00%
Depression: 2 people, 25.00%
Insomnia (sleeplessness): 2 people, 25.00%

What are the existing conditions these people have? *

Parkinson's Disease: 1 person, 12.50%
Osteoporosis (bones weak and more likely to break): 1 person, 12.50%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 1 person, 12.50%
Hypoparathyroidism Secondary (inadequate secretion of parathyroid hormone resulting in abnormally low levels of calcium in the blood -due to another disease): 1 person, 12.50%
Hiv Infection: 1 person, 12.50%
Haemolytic Uraemic Syndrome (blood clotting disease caused by e. coli infection, birth control pills, pneumonia, medications, and more): 1 person, 12.50%
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 1 person, 12.50%
Diabetes: 1 person, 12.50%
Abdominal Pain: 1 person, 12.50%

* Approximation only. Some reports may have incomplete information.

Do you take Zemplar and have Panic attacks?

- Check whether Panic attacks is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Zemplar:

Zemplar (15,494 reports)

Panic attacks treatments and more:

Panic attacks (65,704 reports)

Browse all side effects of Zemplar:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Panic attacks:

Panic attacks (2,290 drugs)

Browse all the conditions that are associated with Panic attacks:

Panic attacks (2,077 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on paricalcitol (the active ingredients of Zemplar) and Zemplar (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.